This site is devoted to helping you understand your stem cell treatment options for Spinal Muscular Atrophy.
Our treatment protocols, which are used in China’s leading hospitals, are a complementary form of therapy that can be used on its own or along with other SMA treatments. Only stem cells from the world’s leading adult stem cell company, Beike Biotechnology, are used.The benefits reported from treatment at partner hospitals with our umbilical cord blood stem cells differ from patient to patient. Some patients find benefits begin near the end of their treatment cycle, while others do not see improvements until two to six months after treatment. Approximately 20% of patients report no improvements. Like any medical procedure, the amount of improvement from stem cell treatment and therapy differs from individual to individual.
The best way to learn more about the experience of past spinal muscular atrophy patients who have received stem cell treatment is to contact us and we can put you in touch with former patients who are willing to share all aspects of their story.
After thoroughly researching stem cell treatment for spinal muscular atrophy and understanding the pros and cons, you may decide you do not want to wait for this treatment to become available in your home country. If so, consider the following points:
Why use umbilical cord blood-derived stem cells for Spinal Muscular Atrophy treatment?
- Beike’s 10+ years of clinical experience indicates that not only are UCBSCs a very safe therapy for SMA patients, but these cells are the most effective at treating the disorder when delivered in accordance with Beike’s spinal muscular atrophy treatment protocol.
- There is no moral dilemma because umbilical cord material is disposed of after birth.
Why use Beike’s stem cells and protocols for treatment?
- Beike’s treatment protocol is comprehensive; it involves six or more injections of at least 10 million stem cells combined with rehab therapy, all delivered in China’s leading hospitals.
- Since 2001, more than 90 spinal muscular atrophy patients and more than 9,000 other patients have received our treatment with no serious complications related to Beike’s stem cells.
- Beike’s stem cell process is the only one with ISO 9001 certification , so you can be confident you are receiving the highest quality stem cells available.
- Beike stem cell laboratories are reviewed and certified by local drug authorities.
- Beike works with more than 30 government and large, state-owned hospitals in China.
- Beike processes are reviewed and approved by an Independent Review Board (IRB) at each partner hospital.
- Beike’s work has been published in multiple peer reviewed journals in China and around the world.
Tidak ada komentar:
Posting Komentar